Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Experimental Hematology

• Publication date

  1985-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 3905427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants.

  1985cited by this paper
• BONE MARROW REPOPULATION CAPACITY AFTER TRANSPLANTATION OF LYMPHOCYTE‐DEPLETED ALLOGENEIC BONE MARROW USING COUNTERFLOW CENTRIFUGATION

  1984cited by this paper
• Depletion of T cells from human bone marrow with monoclonal antibody CT-2 and complement.

  1984cited by this paper
• Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow.

  1984cited by this paper
• The graft-versus-host reaction and immune function. I. T helper cell immunodeficiency associated with graft-versus-host-induced thymic epithelial cell damage.

  1984cited by this paper
• Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease.

  1984cited by this paper
• Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients.

  1984cited by this paper
• Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality.

  1983cited by this paper
• Monoclonal antibody toxin conjugates for experimental graft-versus-host disease prophylaxis. Reagents selectively reactive with T cells and not murine stem cells.

  1983cited by this paper
• Lethal GVHD Across Minor Histocompatibility Barriers: Nature of the Effector Cells and Role of the H‐2 Complex

  1983cited by this paper
• Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia.

  1983cited by this paper
• T CELL DEPLETION OF HUMAN BONE MARROW USING MONOCLONAL ANTIBODY AND COMPLEMENT‐MEDIATED LYSIS

  1983cited by this paper
• Allogeneic Bone‐Marrow Transplantation

  1983cited by this paper
• Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir.

  1983cited by this paper
• HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.

  1983cited by this paper
• POSSIBILITY OF GRAFT‐VS‐LEUKEMIA DETERMINANTS INDEPENDENT OF THE MAJOR HISTOCOMPATIBILITY COMPLEX IN ALLOGENEIC MARROW TRANSPLANTATION

  1983cited by this paper
• Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.

  1982cited by this paper
• Toward safer marrow transplantation.

  1982cited by this paper
• Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency.

  1982cited by this paper
• Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia.

  1982cited by this paper
• Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation.

  1982cited by this paper
• Bone marrow transplantation across major histocompatibility barriers in mice. II. T cell requirement for engraftment in total lymphoid irradiation-conditioned recipients.

  1982cited by this paper
• Antifungal chemotherapy.

  1982cited by this paper
• Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells.

  1981cited by this paper
• Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.

  1981cited by this paper
• Cardiotoxicity associated with high-dose cyclophosphamide therapy.

  1981cited by this paper
• Transplantation of marrow from an unrelated donor to a patient with acute leukemia.

  1980cited by this paper
• Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing.

  1980cited by this paper
• Histocompatibility barriers in human marrow transplantation.

  1980cited by this paper
• Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity

  1979cited by this paper
• HUMAN MARROW TRANSPLANTATION

  1979cited by this paper
• ANTILYMPHOCYTIC ANTIBODIES AND MARROW RANSPLANTATION: VI. GRAFT‐VERSUS-HOST TOLERANCE IN DLA‐INCOMPATIBLE DOGS AFTER IN VITRO TREATMENT OF BONE MARROW WITH ABSORBED ANTITHYMOCYTE GLOBULIN

  1979cited by this paper
• Marrow transplantation from donors other than HLA-identical siblings.

  1979cited by this paper
• A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients.

  1979cited by this paper
• Nonspecific suppressor cells in patients with chronic graft-vs-host disease after marrow grafting.

  1979cited by this paper
• Remission of relapsed leukaemia during a graft-versus-host reaction. A "graft-versus-leukaemia reaction" in man?

  1978cited by this paper
• Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro

  1978cited by this paper
• Fatal graft-versus-host disease after a small leukocyte transfusion in a patient with lymphoma and varicella.

  1978cited by this paper
• Resistance to DLA-nonidentical marrow grafts in lethally irradiated dogs.

  1977cited by this paper
• Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor.

  1977cited by this paper
• Bone-marrow transplantation (first of two parts).

  1975cited by this paper
• Incompatible bone marrow transplantation in lymphopenic immunologic deficiency

  1971cited by this paper
• Genetic factors influencing irradiation protection by bone marrow. III. Midlethal irradiation of inbred mice.

  1963cited by this paper

• Complications of Haploidentical and Mismatched HSC Transplantation

  2020cites this paper
• Historical Perspective and Current Trends in Haploidentical Transplantation

  2018cites this paper
• Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Children

  2016cites this paper
• Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

  2015cites this paper
• IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapy.

  2012cites this paper
• Haploidentical hematopoietic transplantation: current status and future perspectives.

  2011cites this paper
• Graft Manipulation: T Cell Depletion and Tumor Cell Purging

  2008cites this paper
• Partially Mismatched Related Donor Transplantation

  2006cites this paper
• Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignancies

  2005cites this paper
• Bearbeitung und Transplantation hämatopoetischer Stammzellen

  2005cites this paper
• Haploidentical Stem Cell Transplantation

  2004cites this paper
• ADVANCES IN THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER HEMATOPOIETIC CELL TRANSPLANTATION

  2004cites this paper
• Dog leukocyte antigen nonidentical unrelated canine marrow grafts: enhancement of engraftment by CD4 and CD8 T cells

  2003cites this paper
• Immunotherapy of Leukemia

  2003cites this paper
• Successful haematopoietic stem cell transplantation from a matched unrelated donor following three graft failures from HLA-mismatched related donors

  2003cites this paper
• Monoclonal Antibody T-Cell-Depleted HLA-Haploidentical Bone Marrow Transplantation for Wiskott-Aldrich Syndrome

  2003cites this paper
• The role of haploidentical stem cell transplantation in the management of children with haematological disorders

  2003cites this paper
• Depletion of Host Reactive T Cells by Photodynamic Cell Purging and Prevention of Graft Versus Host Disease

  2003cites this paper
• Effect of y Irradiation of Red Blood Cell Units on T-cell Inactivation as Assessed by Limiting Dilution Analysis: Implications for Preventing Transfusion-Associated Graft-Versus-Host Disease

  2002cites this paper
• Antibody-directed, effector cell-mediated tumor destruction.

  2001cites this paper
• The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.

  2001cites this paper
• Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation.

  2001cites this paper
• Transplantation of anergic histoincompatible bone marrow allografts.

  1999cites this paper
• Ten‐year experience of unrelated bone marrow donor transplants in children with malignant and non‐malignant conditions

  1999cites this paper
• Successful unrelated marrow transplantation for patients over the age of 40 with chronic myelogenous leukemia.

  1998cites this paper
• Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation.

  1998cites this paper
• HLA-mismatched family donor transplants: a novel strategy as curative therapy for patients with hematologic disorders.

  1998cites this paper
• Alternative Donor Sources in Pediatric Bone Marrow Transplantation

  1997cites this paper
• A synthetic CD4-CDR3 peptide analog enhances bone marrow engraftment across major histocompatibility barriers.

  1997cites this paper
• A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle Osseuse.

  1996cites this paper
• A phase II trial of partially incompatible bone marrow transplantation for high‐risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti‐LFA‐1 and anti‐CD2 antibodies

  1996cites this paper
• Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant.

  1996cites this paper
• T Cells, Graft-versus-Host Disease and Graft-versus-Leukemia: Innovative Approaches for Blood and Marrow Transplantation

  1996cites this paper
• Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity.

  1996cites this paper
• Specific depletion of alloreactivity against haplotype mismatched related individuals by a recombinant immunotoxin: a new approach to graft-versus-host disease prophylaxis in haploidentical bone marrow transplantation.

  1996cites this paper
• CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors.

  1996cites this paper
• T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation.

  1996cites this paper
• Optimizing the Composition of Bone Marrow for Allogeneic Transplantation

  1995cites this paper
• Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum.

  1994cites this paper
• Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia

  1994cites this paper
• Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease.

  1994cites this paper
• Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia.

  1994cites this paper
• Hematopoietic Engraftment and Graft Failure After Bone Marrow Transplantation

  1993cites this paper
• Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patients.

  1993cites this paper
• Extended-cycle elutriation to adjust T-cell content in HLA-disparate bone marrow transplantation.

  1993cites this paper
• Choosing an alternative bone marrow donor among available family members.

  1993cites this paper
• Prevention and Treatment of Acute Graft‐vs.-Host Disease

  1993cites this paper
• T-Cell Depletion for Allogeneic Bone Marrow Transplantation: Impact on Graft-Versus-Host Disease, Engraftment, and Graft-Versus-Leukemia

  1993cites this paper
• Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.

  1993cites this paper
• Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.

  1992cites this paper
• Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies.

  1991cites this paper
• Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion.

  1991cites this paper
• Hematopoietic chimerism in sheep and nonhuman primates by in utero transplantation of fetal hematopoietic stem cells.

  1991cites this paper
• Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome.

  1990cites this paper
• In utero transplantation of hematopoietic stem cells in sheep: the role of T cells in engraftment and graft-versus-host disease.

  1990cites this paper
• T-cell depletion for bone marrow transplantation: effects on graft rejection, graft-versus-host disease, graft-versus-leukemia, and survival.

  1990cites this paper
• Evidence that anti-asialo GM1 in vivo improves engraftment of T cell-depleted bone marrow in hybrid recipients.

  1990cites this paper
• T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation.

  1990cites this paper
• Bone marrow transplantation for childhood acute lymphoblastic leukaemia after marrow relapse

  1990cites this paper
• Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome

  1990cites this paper
• Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants.

  1989cites this paper
• Immunotherapy of Disease

  1989cites this paper
• Antilymphocyte Antibodies: Polyclonal and Monoclonal

  1989cites this paper
• Bone marrow transplantation with T lymphocyte depleted and stem cell enriched bone marrows grafts : experiments in Rhesus monkeys

  1989cites this paper
• T cell depletion for graft-versus-host-disease prophylaxis. A perspective on engraftment in mice and humans.

  1989cites this paper
• Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants.

  1988cites this paper
• T cell depletion in bone marrow transplantation.

  1988cites this paper
• ENGRAFTMENT FOLLOWING T CELL‐DEPLETED BONE MARROW TRANSPLANTATION: III. DIFFERENTIAL EFFECTS OF INCREASED TOTAL‐BODY IRRADIATION ON SEMIALLOGENEIC AND ALLOGENEIC RECIPIENTS

  1988cites this paper
• Modern management of chronic myelogenous leukemia (CML).

  1988cites this paper
• REGULATION OF CYTOTOXIC T LYMPHOCYTE‐MEDIATED GRAFT REJECTION FOLLOWING BONE MARROW

  1988cites this paper
• Transplantation of marrow from donors other than genotypically HLA-identical siblings.

  1987cites this paper
• Graft-Versus-Host Disease: A Review

  1987cites this paper
• Haploidentical Bone Marrow Transplantation for Osteopetrosis

  1987cites this paper
• Human marrow transplantation: an immunological perspective.

  1987cites this paper
• In vitro chemoseparation of leukemic cells from murine bone marrow using VP16-213: importance of stem cell assays.

  1987cites this paper
• Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation.

  1987cites this paper
• Critical issues in bone marrow transplantation.

  1987cites this paper
• Marrow transplantation: what determines success or failure of hematologic reconstitution?

  1987cites this paper
• Graft failure and leukemia relapse following T lymphocyte-depleted bone marrow transplants: effect of intensification of immunosuppressive conditioning.

  1987cites this paper
• Immune interventions in disease.

  1987cites this paper
• Histoincompatible bone marrow transplants in humans.

  1987cites this paper
• The current status of monoclonal antibodies in the diagnosis and therapy of cancer.

  1986cites this paper
• Acute lymphoblastic leukaemia in adults.

  1986cites this paper
• FAILURE OF ALLOGENEIC CANINE MARROW GRAFTS AFTER TOTAL‐BODY IRRADIATION: ALLOGENEIC “RESISTANCE” VERSUS TRANSFUSION‐INDUCED SENSITIZATION

  1986cites this paper
• Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: autologous marrow recovery with specific immune sensitization to donor antigens.

  1986cites this paper
• In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.

  1986cites this paper
• Prevention of graft-versus-host disease by immunosuppressive agents after transplantation of DLA-nonidentical canine marrow.

  1986cites this paper